We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 517 → 8 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$14K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.29B
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.21B
3
BlackRock
BlackRock
New York
-$1.12B
4
State Street
State Street
Massachusetts
-$509M
5
Primecap Management
Primecap Management
California
-$370M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFBT
451
Parkside Financial Bank & Trust
Missouri
– -$17K -72 Closed
AA
452
Addison Advisors
Vermont
– -$17K -69 Closed
GRP
453
Global Retirement Partners
California
– -$17K -66 Closed
SSG
454
Summit Securities Group
New York
– -$16K -66 Closed
BC
455
Bartlett & Co
Ohio
– -$14K -59 Closed
BCWM
456
Bartlett & Co Wealth Management
Ohio
– -$14.5K -59 Closed
OA
457
Operose Advisors
Wisconsin
– -$13K -53 Closed
PTC
458
Private Trust Company
Ohio
– -$11K -46 Closed
SIA
459
Sit Investment Associates
Minnesota
– -$11K -45 Closed
SC
460
Steph & Co
Wisconsin
– -$11K -45 Closed
HWMA
461
Heritage Wealth Management (Arizona)
Arizona
– -$10K -42 Closed
OIA
462
Optimum Investment Advisors
Illinois
– -$10K -40 Closed
SSB
463
Sandy Spring Bank
Maryland
– -$10K -40 Closed
ST
464
Smithfield Trust
Pennsylvania
– -$10K -38 Closed
GWS
465
Glassman Wealth Services
Virginia
– -$9K -37 Closed
FMII
466
Farmers & Merchants Investments Inc
Nebraska
– -$7K -30 Closed
BFEC
467
Benjamin F. Edwards & Company
Missouri
– -$7K -29 Closed
AIP
468
Almanack Investment Partners
Pennsylvania
– -$7K -28 Closed
EARNEST Partners
469
EARNEST Partners
Georgia
– -$6K -23 Closed
EW
470
Evoke Wealth
California
– -$5K -22 Closed
CA
471
Crewe Advisors
Utah
– -$5K -21 Closed
BIA
472
Bell Investment Advisors
California
– -$4K -18 Closed
MPWT
473
MassMutual Private Wealth & Trust
Connecticut
– -$4K -17 Closed
MCM
474
MV Capital Management
Maryland
– -$4K -17 Closed
VNA
475
Valley National Advisers
Pennsylvania
– -$4K -17 Closed
16 17 18
19
20

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.